Clinical trials recruiting for Hypercholesterolemia
19
Recruiting trials
23
US states with sites
17
Countries
5%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| North Carolina | 3 |
| Florida | 2 |
| Texas | 2 |
| Alabama | 1 |
| California | 1 |
| Georgia | 1 |
| Hawaii | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kentucky | 1 |
| Louisiana | 1 |
| Maryland | 1 |
Top cities
Clearwater, Florida 2Dallas, Texas 2Durham, North Carolina 2Addison, Illinois 1Anaheim, California 1Anniston, Alabama 1Bethesda, Maryland 1Butte, Montana 1Charlottesville, Virginia 1Columbus, Ohio 1
Self-screener
Recruiting trials
- A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
- A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
- A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
- A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
- A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Alirocumab in Patients on a Stable Dialysis Regimen
- Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
- Causes and Natural History of Dyslipidemias
- Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention
- Effect of Two Food Supplements on Lipid Profile in Patients With Mild Hypercholesterolemia
- Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
- Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
- Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
- Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
- Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
- PMMHRI-Pitavastatin Registry
- Pharmacogenomic Informed Statin Prescribing
- Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Related conditions
Trials recruiting for Hypercholesterolemia often also study these conditions. Each links to its own recruiting-trial list.
High cholesterol 103Atherosclerosis 21Cardiovascular Diseases 164Dyslipidemias 22Renal Insufficiency 6Peritoneal Dialysis 3Obesity 1512Metabolic Disease 28Lipid Disorder 5Hypertriglyceridemia 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hypercholesterolemia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.